Invenio Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Buy
568
+19
+3% +$9.12K 0.1% 77
2026
Q1
$270K Buy
549
+66
+14% +$35.8K 0.11% 75
2025
Q4
$280K Sell
483
-4
-0.8% -$2.26K 0.1% 81
2025
Q3
$236K Buy
+487
New +$227K 0.09% 89
2025
Q2
Sell
-504
Closed -$251K 104
2025
Q1
$251K Buy
504
+92
+22% +$49.8K 0.11% 78
2024
Q4
$214K Hold
412
0.09% 94
2024
Q3
$255K Sell
412
-61
-13% -$36.1K 0.11% 88
2024
Q2
$262K Sell
473
-30
-6% -$17.2K 0.13% 81
2024
Q1
$292K Sell
503
-33
-6% -$18.5K 0.16% 72
2023
Q4
$285K Sell
536
-49
-8% -$23.7K 0.21% 71
2023
Q3
$296K Buy
585
+23
+4% +$12.3K 0.27% 63
2023
Q2
$293K Buy
+562
New +$303K 0.33% 56

Other funds holding TMO

Invenio Wealth Partners's TMO Position: Q2 2026 in Review

Invenio Wealth Partners increased its Thermo Fisher Scientific (TMO) stake by 3.5% in Q2 2026, buying an estimated $9.12K and bringing the position to 568 shares worth $285K. The position accounts for 0.1% of the portfolio, ranked #77.

Invenio Wealth Partners first reported a position in TMO in Q2 2023 and has held it in 12 quarters since. The position peaked at $296K in Q3 2023. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Invenio Wealth Partners held 568 shares of Thermo Fisher Scientific worth $285K as of Q2 2026.
  • Invenio Wealth Partners bought 19 Thermo Fisher Scientific shares in Q2 2026, an estimated $9.12K.
  • Thermo Fisher Scientific made up 0.1% of Invenio Wealth Partners's portfolio in Q2 2026, its #77 holding.
  • Invenio Wealth Partners first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 12 quarters since.
  • Invenio Wealth Partners's Thermo Fisher Scientific position peaked at $296K in Q3 2023.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Invenio Wealth Partners's 13F filing for Q2 2026, filed 30 Jul 2026.